Navigation Links
Producing Vaccines from genetically modified crops

The consortium, called Pharma-Planta, wants to produce vaccines and other treatments for major //diseases, such as HIV/Aids, rabies and TB and they hope to start clinical trials by the year 2009. The project's aim is to focus on areas that will be of greatest benefit to developing nations where they feel that access to most vaccines is very poor at the same time keeping in mind that human health and the environment are protected.

The first product, possibly grown in maize, is likely to be an antibody that can be used to block HIV transmission and it has been decided to incorporate it into a microbicidal cream that could be used in the vagina. The second product will probably to be a post-bite vaccine for rabies, which is still a significant killer in Africa and southeast Asia.

Researchers at Pharma –Planta say that the plants will be grown in pharmaceutical production units on dedicated land , isolated from food crops. Thirty-nine labs in 11 European countries will work together, with input from researchers in South Africa, where HIV/Aids is a major public health issue. Scientific co-ordinators at Pharma –Planta say many commercial companies have withdrawn from vaccine development and production because of low economic returns ,however they say that Pharma-Planta hopes the technology it will develop over the course of its initial five years of funding will eventually boost the global supply of treatments.

Current methods used include genetic modification of human cells and microorganisms such as bacteria. These techniques are labour intensive, expensive and often only produce relatively small amounts of pharmaceuticals. Researchers at Pharma – Planta say that plants are inexpensive to grow as well as to engineer them to contain a gene for a pharmaceutical product and most importantly they could produce large quantities of drugs or vaccines at low cost. The project has yet to decide which plants to use but some of the plants mos t likely to be used include tobacco, maize, potatoes and tomatoes. Although Pharma- Planta claims to maintain and follow the ideal conditions and procedures for their project others are of the opinion that Pharma- Planta’s research could have widespread negative impacts and also suggest that a clear set of criteria must be established to ensure that human health and the environment are protected

'"/>




Related medicine news :

1. A New study Throws Light On The Growth & Functions Of Insulin Producing Beta Cells
2. New Technique Developed By Scientists For Producing Stem Cells without Damaging Embryos
3. Producing More Drugs For Lethal Diseases Is Not The Answer
4. A Combined Research for Producing Chlamydia Vaccine Begins
5. Height of Liberation – Lesbians, No Less in Producing Babies (read Daughters
6. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
7. New Anthrax Vaccines Will Take time
8. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
9. Health and Human Services stockpiles 20 million bird flu Vaccines
10. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
11. Oral Edible vaccine for Allergy Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... ... The Radiology Business Management Association (RBMA) has named the nine winners ... year, are among the most prestigious in radiology marketing because a panel of radiology ... recognize achievements in both large budget (over $5,000) and small budget (under $5,000) campaigns. ...
(Date:3/24/2017)... ... 24, 2017 , ... Mlynarek Insurance Agencies, a Detroit area ... owners across eastern Michigan, is connecting with the Oxford/Orion FISH Food Pantry for ... The Oxford/Orion FISH Food Pantry works to ensure homeless, hungry, and underprivileged families ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge dentists, Dr. ... for sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, ... obstructive type, is increasingly being treated at dental offices with newly developed procedures ...
(Date:3/24/2017)... ... 24, 2017 , ... Gastro Health (“GH”) ( http://www.gastrohealth.com ... for colonoscopy at the HyGIeaCare® Center that is to be located adjacent to ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration (FDA), ...
(Date:3/24/2017)... ... ... Time GPS”: a dauntless and enlightened study of the second-coming of Christ, and ... published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation as ... ninety-one, he shares the Wisdom God bestowed upon him in this publication. , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)...  Transportation Insight, a multi-modal lead logistics solutions provider ... firm with expertise serving clients in the food industry. ... was named a 2017 Food Logistics ... only publication exclusively dedicated to covering the movement of ... "Rick has brought to Transportation Insight a wealth of ...
(Date:3/23/2017)... and INDIANAPOLIS , March 23, 2017 ... ) and the William Sansum Diabetes Center have established ... people affected by diabetes through enhanced research, education and ... and cardiovascular disease bears a disproportionate weight on Latino ... said David Kerr , M.D., FRCPE, director of ...
(Date:3/23/2017)...  The U.S. Food and Drug Administration today granted ... adults and pediatric patients 12 years and older with ... not received prior chemotherapy. This is the first FDA-approved ... skin cancer. "While skin cancer is one ... form called Merkel cell cancer have not had an ...
Breaking Medicine Technology: